 New potent verapamil derivatives multidrug resistance human renal carcinoma cells transgenic mice human gene Multidrug resistance human renal cell carcinoma expression gene broad spectrum cross resistance many natural product chemotherapeutic agents resistance chemosensitizers function gene product P-glycoprotein development new agents side effects potency resistance high priority research drug resistance new verapamil derivatives primary human renal cell carcinomas vitro MDR-transgenic mice model mice human gene bone marrow cells measurement white blood counts simple rapid reliable system potency MDR-reversing agents vivo drugs effective multidrug resistance primary cultures human renal cell carcinomas combination vinblastine chemotherapy extent doxorubicin daunomycin chemotherapy vivo data agents low toxicity high concentrations effective low achievable concentrations drugs R-verapamil results new drugs attractive candidates clinical trials